# Petmed Express Inc: Form 10-Q for the period ended Dec 31, 2019

- Company: [Petmed Express Inc](/companies/pets.md) (CIK 1040130)
- Form: 10-Q
- Filed: 2020-01-28
- Accepted by EDGAR: Jan 28, 2020, 12:01 ET
- Period: 2019-12-31
- Accession: 0001437749-20-001273
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1040130/000143774920001273/pets20191231_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1040130/000143774920001273/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 9 months, 2019-04-01 to 2019-12-31 | $209.8m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2019-10-01 to 2019-12-31 | $42.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-04-01 to 2019-12-31 | $150.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2019-10-01 to 2019-12-31 | $17.7m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-04-01 to 2019-12-31 | $59.6m | us-gaap:GrossProfit |
| Operating income | 3 months, 2019-10-01 to 2019-12-31 | $7.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-04-01 to 2019-12-31 | $22.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2019-10-01 to 2019-12-31 | $1.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-04-01 to 2019-12-31 | $5.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-10-01 to 2019-12-31 | $6.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-04-01 to 2019-12-31 | $18.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-10-01 to 2019-12-31 | $0.34 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-04-01 to 2019-12-31 | $0.94 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-10-01 to 2019-12-31 | $0.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-04-01 to 2019-12-31 | $0.94 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-10-01 to 2019-12-31 | 19,994,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-04-01 to 2019-12-31 | 20,071,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-04-01 to 2019-12-31 | $21.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-04-01 to 2019-12-31 | $1.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2019-04-01 to 2019-12-31 | $16.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2019-04-01 to 2019-12-31 | $11.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-12-31 | $92.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-12-31 | $122.8m | us-gaap:AssetsCurrent |
| Total assets | at 2019-12-31 | $149.5m | us-gaap:Assets |
| Current liabilities | at 2019-12-31 | $20.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-12-31 | $21.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2019-12-31 | $127.7m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1040130/000143774920001273/pets20191231_10q.htm

Filed Jan 28, 2020.
Source: SEC EDGAR, the filing index for accession 0001437749-20-001273. Last ingested by Listed: Nov 13, 2026, 14:26 ET. No prices; not investment advice.
